Tsumura & Co. (TYO:4540)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Products	192.62B	181.09B	150.85B	140.04B	129.55B
Pharmaceutical Products Growth	6.36%	20.05%	7.71%	8.10%	-1.02%
Total	192.62B	181.09B	150.85B	140.04B	129.55B
Total Growth	6.36%	20.05%	7.71%	8.10%	-1.02%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	161.17B	161.67B	133.37B	124.68B	119.57B
Japan Growth	-0.31%	21.22%	6.97%	4.28%	-8.65%
China	31.44B	16.02B	14.86B	-	-
China Growth	96.22%	7.86%	-	-	-
Others	-	3.40B	2.62B	-	-
Others Growth	-	29.89%	-	-	-
Overseas	-	-	-	15.36B	9.98B
Overseas Growth	-	-	-	53.93%	-
Total	192.61B	181.09B	150.84B	140.04B	129.55B
Total Growth	6.36%	20.05%	7.71%	8.10%	-1.02%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error